Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease

Gene Expression

Volumn 13, Issue 3, 2006, Pages 205-215

  Papapetropoulos, Spiridon ^a   Ffrench Mullen, Jarlath ^b   McCorquodale, Donald ^a   Qin, Yujing ^a   Pablo, John ^a   Mash, Deborah C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Gene Logic Inc   (United States)

Author keywords

Microarray; Mitoribosome; MRPS6; Parkinson's disease; Postmortem

Indexed keywords

AGED; APOPTOSIS; ARTICLE; AUTOPSY; BIOINFORMATICS; BRAIN REGION; CELL CYCLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MRPS6 GENE; NERVE DEGENERATION; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PATHOGENESIS; SIGNAL TRANSDUCTION; ADULT; AGING; DNA MICROARRAY; GENETICS; METABOLISM; MIDDLE AGED; SUBSTANTIA NIGRA;

BIOLOGICAL MARKER; MESSENGER RNA; MITOCHONDRIAL PROTEIN; PROTEIN S6;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; RIBOSOMAL PROTEIN S6; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 34347346696     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783991827     Document Type: Article

References (50)

1. Bentley, C. A.; Lee, K. F. p75 is important for axon growth and Schwann cell migration during development. J. Neurosci. 20:7706-7715; 2000.
2. Bernardi, P.; Scorrano, L.; Colonna, R.; Petronilli, V.; Di Lisa, F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur. J. Biochem. 264:687-701; 1999.
3. Blochl, A.; Sirrenberg, C. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J. Biol. Chem. 271:21100-21107; 1996.
4. Bonifati, V.; Rizzu, P.; van Baren, M. J.; et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256-259; 2003.
5. Brann, A. B.; Scott, R.; Neuberger, Y.; et al. Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J. Neurosci. 19:8199-8206; 1999.
6. Brenner, C.; Kroemer, G. Apoptosis. Mitochondria - the death signal integrators. Science 289:1150-1151; 2000.
7. Carim, L.; Sumoy, L.; Nadal, M.; Estivill, X.; Escarceller, M. Cloning, expression, and mapping of PDCD9, the human homolog of Gallus gallus proapoptotic protein p52. Cytogenet. Cell Genet. 87:85-88; 1999.
8. Cavdar Koc, E.; Ranasinghe, A.; Burkhart, W.; et al. A new face on apoptosis: Death-associated protein 3 and PDCD9 are mitochondrial ribosomal proteins. FEBS Lett. 492:166-170; 2001.
9. Chabrol, B.; Sigaudy, S.; Paquis, V.; et al. Stuve-Wiedemann syndrome and defects of the mitochondrial respiratory chain. Am. J. Med. Genet. 72:222-226; 1997.
10. Chaib, H.; Kaplan, J.; Gerber, S.; et al. A newly identified locus for Usher syndrome type I, USH1E, maps to chromosome 21q21. Hum. Mol. Genet. 6:27-31; 1997.
11. Crompton, M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341(Pt. 2):233-249; 1999.
12. Dahl, H. H. Getting to the nucleus of mitochondrial disorders: Identification of respiratory chain-enzyme genes causing Leigh syndrome. Am. J. Hum. Genet. 63:1594-1597; 1998.
13. Fairer, M. J. Genetics of Parkinson disease: Paradigm shifts and future prospects. Nat. Rev. Genet. 7:306-318; 2006.
14. Gandhi, S.; Wood, N. W. Molecular pathogenesis of Parkinson's disease. Hum. Mol. Genet. 14:2749-2755; 2005.
15. Giaccia, A. J.; Kastan, M. B. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev. 12:2973-2983; 1998.
16. Gottlieb, R. A. Mitochondria: Execution central. FEBS Lett. 482:6-12; 2000.
17. Gray, M. W.; Burger, G.; Lang, B. F. The origin and early evolution of mitochondria. Genome Biol. 2:RE VIEWS1018; 2001.
18. Grunblatt, E.; Mandel, S.; Jacob-Hirsch, J.; et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J. Neural Transm. 111:1543-1573; 2004.
19. Hauser, M. A.; Li, Y. J.; Xu, H.; et al. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch. Neurol. 62:917-921; 2005.
20. Higuchi, H.; Yamashita, T.; Yoshikawa, H.; Tohyama, M. PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts. EMBO J. 22:1790-1800; 2003.
21. Hoehn, M. M.; Yahr, M. D. Parkinsonism: Onset, progression and mortality. Neurology 17:427-442; 1967.
22. Hughes, A. J.; Daniel, S. E.; Kilford, L.; Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55:181-184; 1992.
23. Jacobs, H. T.; Turnbull, D. M. Nuclear genes and mitochondrial translation: A new class of genetic disease. Trends Genet. 21:312-314; 2005.
24. Jin, A.; Itahana, K.; O'Keefe, K.; Zhang, Y. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol. 24:7669-7680; 2004.
25. Kissil, J. L.; Cohen, O.; Raveh, T.; Kimchi, A. Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell death. EMBO J. 18:353-362; 1999.
26. Kissil, J. L.; Deiss, L. P.; Bayewitch, M.; Raveh, T.; Khaspekov, G.; Kimchi, A. Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death. J. Biol. Chem. 270:27932-27936; 1995.
27. Mackenzie, B.; Erickson, J. D. Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch. 447:784-795; 2004.
28. Mandel, S.; Grunblatt, E.; Riederer, P.; et al. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann. NY Acad. Sci. 1053:356-375; 2005.
29. Maraganore, D. M.; de Andrade, M.; Lesnick, T. G.; et al. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 77:685-693; 2005.
30. Monk, D.; Bentley, L.; Hitchins, M.; et al. Chromosome 7p disruptions in Silver Russell syndrome: Delineating an imprinted candidate gene region. Hum. Genet. 111:376-387; 2002.
31. Moran, L. B.; Duke, D. C.; Deprez, M.; Dexter, D. T.; Pearce, R. K.; Graeber, M. B. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 7:1-11; 2006.
32. O'Brien, T. W. Properties of human mitochondrial ribosomes. IUBMB Life 55:505-513; 2003.
33. O'Brien, T. W.; O'Brien, B. J.; Norman, R. A. Nuclear MRP genes and mitochondrial disease. Gene 354:147-151; 2005.
34. Ogden, C. A.; Rich, M. E.; Schork, N. J.; et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: An expanded convergent functional genomics approach. Mol. Psychiatry 9:1007-1029; 2004.
35. Papapetropoulos, S.; Villar, J. M.; Gonzalez, J.; Mash, D. C. Disparities in death certificates of Parkinson's disease patients: A report from a population of brain donors. Mov. Disord. 21:1791-1792; 2006.
36. Riepe, R. E.; Norenberg, M. D. Glutamine synthetase in the developing rat retina: an immunohistochemical study. Exp. Eye Res. 27:435-444; 1978.
37. Schieber, G. L.; O'Brien, T. W. Extraction of proteins from the large subunit of bovine mitochondrial ribosomes under nondenaturing conditions. J. Biol. Chem. 257:8781-8787; 1982.
38. Seyda, A.; Newbold, R. F.; Hudson, T. J.; et al. A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am. J. Hum. Genet. 68:386-396; 2001.
39. Sun, L.; Liu, Y.; Fremont, M.; et al. A novel 52 kDa protein induces apoptosis and concurrently activates c-Jun N-terminal kinase 1 (JNK1) in mouse C3H10T1/2 fibroblasts. Gene 208:157-166; 1998.
40. Sylvester, J. E.; Fischel-Ghodsian, N.; Mougey, E. B.; O'Brien, T. W. Mitochondrial ribosomal proteins: candidate genes for mitochondrial disease. Genet. Med. 6:73-80; 2004.
41. Umapathy, N. S.; Li, W.; Mysona, B. A.; Smith, S. B.; Ganapathy, V. Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Muller cells. Invest. Ophthalmol. Vis. Sci. 46:3980-3987; 2005.
42. Valente, E. M.; Abou-Sleiman, P. M.; Caputo, V.; et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160; 2004.
43. Vandesompele, J.; De Preter, K.; Pattyn, F.; et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034; 2002.
44. Vernon, A. C.; Palmer, S.; Datla, K. P.; Zbarsky, V.; Croucher, M. J.; Dexter, D. T. Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease. Eur. J. Neurosci. 22:1799-1806; 2005.
45. Williams, D. R.; Hadeed, A.; al-Din, A. S.; Wreikat, A. L.; Lees, A. J. Kufor Rakeb disease: Autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov. Disord. 20:1264-1271; 2005.
46. Wu, J.; Luo, S.; Jiang, H.; Li, H. Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein. FEBS Lett. 579:421-426; 2005.
47. Yoo, Y. A.; Kim, M. J.; Park, J. K.; et al. Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1. Mol. Cell. Biol. 25:6603-6616; 2005.
48. Young, J. Z.; Isiegas, C.; Abel, T.; Nguyen, P. V. Metaplasticity of the late-phase of long-term potentiation: A critical role for protein kinase A in synaptic tagging. Eur. J. Neurosci. 23:1784-1794; 2006.
49. Zhang, Y.; James, M.; Middleton, F. A.; Davis, R. L. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 137:5-16; 2005.
50. Zimprich, A.; Biskup, S.; Leitner, P.; et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601-607; 2004.